Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation report a 4.82% stake in Bolt Biotherapeutics, reflecting ongoing industry interest.
| Name | Bolt Biotherapeutics, Inc. |
|---|---|
| CIK | 0001641281 |
| Tickers | BOLT |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 472804636 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 650-665-9295 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation report a 4.82% stake in Bolt Biotherapeutics, reflecting ongoing industry interest.
Bolt Biotherapeutics, Inc. reports its third-quarter financial results, reflecting ongoing efforts in pharmaceutical preparations and strategic advancements.
Sheila Gujrathi, Chief Strategy Officer of Bolt Biotherapeutics, files Form 3, indicating ownership changes and strategic direction in the pharmaceutical sector.
Bolt Biotherapeutics discloses stock transactions after merging with Prana Therapies, reflecting ongoing trends in the pharmaceutical industry.
Bolt Biotherapeutics, Inc. has acquired Prana Therapies, Inc., enhancing its position in the pharmaceutical preparations sector.
301 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-129252 | 8945 | ||||||
| 2026-11-13 | 10-Q | 10-Q | 0001193125-26-458877 | 001-39988 | 261548470 | 34 | 11991401 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-458403 | 001-39988 | 261547068 | 34 | 564655 | 1 | 1 |
| 2026-11-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001037389-26-000063 | 005-92160 | 261546455 | 34 | 9479 | |||
| 2026-11-10 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-125077 | 7288 | ||||||
| 2026-11-06 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-124005 | 17997 | ||||||
| 2026-11-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-123999 | 005-92160 | 261533267 | 34 | 26525 | |||
| 2026-10-27 | 4 | 4 | 0001193125-26-434468 | 13473 | ||||||
| 2026-10-27 | 3 | 3 | 0001193125-26-434466 | 13159 | ||||||
| 2026-10-23 | 8-K | 8-K | 1.01,1.02,2.01,3.02,5.02,5.03,7.01,8.01,9.01 | 0001193125-26-429647 | 001-39988 | 261480446 | 34 | 12953092 | 1 | 1 |
| 2026-10-06 | 8-K | 8-K | 1.01 | 0001193125-26-415560 | 001-39988 | 261444084 | 34 | 159255 | 1 | 1 |
| 2026-09-21 | 4 | 4 | 0001193125-26-396894 | 9142 | ||||||
| 2026-09-21 | 4 | 4 | 0001193125-26-396892 | 10721 | ||||||
| 2026-09-21 | 4 | 4 | 0001193125-26-396890 | 10732 | ||||||
| 2026-08-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001037389-26-000047 | 005-92160 | 261273784 | 34 | 9348 | |||
| 2026-08-11 | 10-Q | 10-Q | 0001193125-26-344597 | 001-39988 | 261263182 | 34 | 8639263 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-344580 | 001-39988 | 261263113 | 34 | 536757 | 1 | 1 |
| 2026-06-11 | 4 | 4 | 0001193125-26-267560 | 5569 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267558 | 5529 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267546 | 5572 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267533 | 5551 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267518 | 5518 | ||||||
| 2026-06-11 | 8-K | 8-K | 5.07 | 0001193125-26-267487 | 001-39988 | 261083019 | 34 | 176283 | 1 | 1 |
| 2026-05-12 | 10-Q | 10-Q | 0001193125-26-219382 | 001-39988 | 26968480 | 34 | 7754975 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-219361 | 001-39988 | 26968407 | 34 | 485822 | 1 | 1 |
| 2026-04-28 | ARS | ARS | 0001193125-26-186950 | 001-39988 | 26907708 | 34 | 63672621 | |||
| 2026-04-28 | DEFA14A | DEFA14A | 0001193125-26-186940 | 001-39988 | 26907621 | 34 | 1342432 | 1 | 1 | |
| 2026-04-28 | DEF 14A | DEF 14A | 0001193125-26-186923 | 001-39988 | 26907566 | 34 | 2511163 | 1 | 1 | |
| 2026-03-12 | S-8 | S-8 | 0001193125-26-104164 | 333-294245 | 26747897 | 33 | 433166 | 1 | 1 | |
| 2026-03-12 | 10-K | 10-K | 0001193125-26-104121 | 001-39988 | 26747690 | 34 | 13575346 | 1 | 1 | |
| 2026-03-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-104102 | 001-39988 | 26747622 | 34 | 552304 | 1 | 1 |
| 2026-02-26 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001012975-26-000212 | 005-92160 | 26691577 | 34 | 62082 | |||
| 2026-02-17 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001012975-26-000173 | 005-92160 | 26644779 | 34 | 58577 | |||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-26-016669 | 005-92160 | 26635363 | 34 | 13916 | |||
| 2026-02-04 | 4 | 4 | 0001193125-26-037697 | 7100 | ||||||
| 2026-02-04 | 4 | 4 | 0001193125-26-037692 | 5457 | ||||||
| 2026-02-04 | 4 | 4 | 0001193125-26-037690 | 7089 | ||||||
| 2025-12-16 | 4 | 4 | 0001193125-25-321156 | 20788 | ||||||
| 2025-12-16 | 4 | 4 | 0001193125-25-321154 | 32840 | ||||||
| 2025-12-16 | 4 | 4 | 0001193125-25-321153 | 24990 | ||||||
| 2025-12-16 | 4 | 4 | 0001193125-25-321152 | 33038 | ||||||
| 2025-12-16 | 4 | 4 | 0001193125-25-321150 | 28833 | ||||||
| 2025-12-16 | 4 | 4 | 0001193125-25-321149 | 42279 | ||||||
| 2025-12-16 | 4 | 4 | 0001193125-25-321148 | 55169 | ||||||
| 2025-12-16 | 4 | 4 | 0001193125-25-321146 | 38290 | ||||||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-016687 | 005-92160 | 251486558 | 34 | 14164 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-016680 | 005-92160 | 251486437 | 34 | 14164 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-277549 | 001-39988 | 251472711 | 34 | 8736121 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-277521 | 001-39988 | 251472601 | 34 | 560796 | 1 | 1 |
| 2025-10-24 | 4 | 4 | 0001193125-25-250334 | 6626 | ||||||
| 2025-10-24 | 4 | 4 | 0001193125-25-250333 | 5097 | ||||||
| 2025-10-24 | 4 | 4 | 0001193125-25-250332 | 6667 | ||||||
| 2025-10-02 | 8-K | 8-K | 2.05,8.01 | 0001193125-25-228293 | 001-39988 | 251368928 | 34 | 205370 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-012265 | 005-92160 | 251219282 | 34 | 14300 | |||
| 2025-08-14 | 10-Q | 10-Q | 0001641281-25-000007 | 001-39988 | 251218986 | 34 | 8596974 | 1 | 1 | |
| 2025-08-14 | 8-K | 8-K | 2.02,9.01 | 0001641281-25-000006 | 001-39988 | 251218792 | 34 | 559326 | 1 | 1 |
| 2025-07-02 | 4 | 4 | 0000950170-25-092941 | 5956 | ||||||
| 2025-07-02 | 4 | 4 | 0000950170-25-092940 | 5953 | ||||||
| 2025-07-02 | 4 | 4 | 0000950170-25-092939 | 5902 | ||||||
| 2025-07-02 | 4 | 4 | 0000950170-25-092938 | 5814 | ||||||
| 2025-07-02 | 4 | 4 | 0000950170-25-092937 | 5935 | ||||||
| 2025-06-06 | 8-K | 8-K | 3.01,5.03 | 0000950170-25-083180 | 001-39988 | 251031322 | 34 | 186924 | 1 | 1 |
| 2025-06-04 | 8-K | 8-K | 8.01 | 0000950170-25-081607 | 001-39988 | 251023098 | 34 | 157249 | 1 | 1 |
| 2025-05-28 | 8-K | 8-K | 5.07 | 0000950170-25-077880 | 001-39988 | 25990166 | 34 | 186887 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-007869 | 005-92160 | 25953329 | 34 | 28065 | |||
| 2025-05-12 | 10-Q | 10-Q | 0000950170-25-069188 | 001-39988 | 25934831 | 34 | 7578569 | 1 | 1 | |
| 2025-05-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-069153 | 001-39988 | 25934677 | 34 | 508442 | 1 | 1 |
| 2025-05-05 | 4 | 4 | 0000950170-25-063886 | 5390 | ||||||
| 2025-05-05 | 4 | 4 | 0000950170-25-063848 | 5450 | ||||||
| 2025-05-05 | 4 | 4 | 0000950170-25-063846 | 8559 | ||||||
| 2025-05-05 | 4 | 4 | 0000950170-25-063840 | 8599 | ||||||
| 2025-04-25 | ARS | ARS | 0000950170-25-058668 | 001-39988 | 25873555 | 34 | 3707052 | |||
| 2025-04-25 | DEF 14A | DEF 14A | 0000950170-25-058632 | 001-39988 | 25873523 | 34 | 4941354 | 1 | 1 | |
| 2025-04-16 | 8-K | 8-K | 5.03,9.01 | 0000950170-25-054871 | 001-39988 | 25843630 | 34 | 464697 | 1 | 1 |
| 2025-04-16 | PRE 14A | PRE 14A | 0000950170-25-054405 | 001-39988 | 25840890 | 34 | 1642396 | |||
| 2025-04-15 | DEF 14A | DEF 14A | 0000950170-25-054294 | 001-39988 | 25840086 | 34 | 1642389 | |||
| 2025-03-24 | S-8 | S-8 | 0000950170-25-043900 | 333-286056 | 25764563 | 33 | 238573 | |||
| 2025-03-24 | 10-K | 10-K | 0000950170-25-043873 | 001-39988 | 25764484 | 34 | 12678134 | 1 | 1 | |
| 2025-03-24 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-043869 | 001-39988 | 25764473 | 34 | 547421 | 1 | 1 |
| 2025-01-03 | 8-K | 8-K | 3.01 | 0000950170-25-001159 | 001-39988 | 25506161 | 34 | 159108 | 1 | 1 |
| 2024-12-23 | 8-K | 8-K | 5.02 | 0000950170-24-139580 | 001-39988 | 241573701 | 34 | 154275 | 1 | 1 |
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-118970 | 005-92160 | 241462709 | 34 | 136655 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-125413 | 001-39988 | 241448312 | 34 | 7168683 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-125376 | 001-39988 | 241448127 | 34 | 450566 | 1 | 1 |
| 2024-09-06 | 4 | xslF345X05/form4-09062024_040947.xml | 0001415889-24-023005 | 8152 | ||||||
| 2024-09-06 | 3 | xslF345X02/form3-09062024_040947.xml | 0001415889-24-023004 | 9100 | ||||||
| 2024-09-04 | 8-K | 8-K | 5.02 | 0001193125-24-213225 | 001-39988 | 241278486 | 34 | 149276 | 1 | 1 |
| 2024-08-13 | 10-Q | 10-Q | 0000950170-24-096200 | 001-39988 | 241201500 | 34 | 7118439 | 1 | 1 | |
| 2024-08-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-096191 | 001-39988 | 241201451 | 34 | 443973 | 1 | 1 |
| 2024-07-24 | 4 | 4 | 0000950170-24-086153 | 5457 | ||||||
| 2024-07-24 | 4 | 4 | 0000950170-24-086146 | 5478 | ||||||
| 2024-07-24 | 4 | 4 | 0000950170-24-086136 | 7600 | ||||||
| 2024-07-03 | 8-K | 8-K | 3.01 | 0001193125-24-175113 | 001-39988 | 241100948 | 34 | 147117 | 1 | 1 |
| 2024-06-14 | 4 | 4 | 0000950170-24-073918 | 5394 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073906 | 5392 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073898 | 5425 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073892 | 5456 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073889 | 5304 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073882 | 5401 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073879 | 5443 | ||||||
| 2024-06-14 | 8-K | 8-K | 5.07 | 0000950170-24-073501 | 001-39988 | 241043986 | 34 | 170182 | 1 | 1 |
| 2024-05-20 | DEFA14A | DEFA14A | 0000950170-24-062226 | 001-39988 | 24963559 | 34 | 29817 | |||
| 2024-05-15 | 3 | 3 | 0000950170-24-060630 | 24250 | ||||||
| 2024-05-14 | 10-Q | 10-Q | 0000950170-24-059564 | 001-39988 | 24944516 | 34 | 6387744 | 1 | 1 | |
| 2024-05-14 | 8-K | 8-K | 2.01,2.05,5.02,9.01 | 0000950170-24-059524 | 001-39988 | 24944289 | 34 | 594604 | 1 | 1 |
| 2024-04-26 | ARS | ARS | 0000950170-24-049111 | 001-39988 | 24883725 | 34 | 4139954 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0000950170-24-049104 | 001-39988 | 24883671 | 34 | 2164560 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0000950170-24-049095 | 001-39988 | 24883592 | 34 | 4904925 | |||
| 2024-03-21 | S-8 | S-8 | 0000950170-24-034711 | 333-278141 | 24771565 | 33 | 222417 | |||
| 2024-03-21 | 10-K | 10-K | 0000950170-24-034692 | 001-39988 | 24771437 | 34 | 10381901 | 1 | 1 | |
| 2024-03-21 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-034688 | 001-39988 | 24771378 | 34 | 437386 | 1 | 1 |
| 2024-03-06 | 4 | 4 | 0000950170-24-026999 | 5455 | ||||||
| 2024-03-06 | 4 | 4 | 0000950170-24-026998 | 5468 | ||||||
| 2024-03-06 | 4 | 4 | 0000950170-24-026997 | 5441 | ||||||
| 2024-03-06 | 4 | 4 | 0000950170-24-026996 | 5479 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023934 | 005-92160 | 24639956 | 34 | 136872 | |||
| 2024-02-14 | SC 13G/A | AMENDMENT NO.1 | 0001214659-24-002866 | 005-92160 | 24637369 | 34 | 77898 | |||
| 2024-02-13 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-24-013397 | 005-92160 | 24627540 | 34 | 115684 | |||
| 2024-02-12 | SC 13D/A | SC 13D/A | 0001193125-24-032572 | 005-92160 | 24622352 | 34 | 180722 | |||
| 2024-02-06 | 5 | FORM 5 SUBMISSION | 0001209191-24-002901 | 4993 | ||||||
| 2024-02-06 | 5 | FORM 5 SUBMISSION | 0001209191-24-002899 | 6574 | ||||||
| 2024-02-06 | 5 | FORM 5 SUBMISSION | 0001209191-24-002897 | 6548 | ||||||
| 2023-12-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-058458 | 7911 | ||||||
| 2023-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-057049 | 12146 | ||||||
| 2023-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-056548 | 8120 | ||||||
| 2023-11-22 | 4 | xslF345X05/ownership.xml | 0001213900-23-089692 | 21108 | ||||||
| 2023-11-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-056185 | 16153 | ||||||
| 2023-11-20 | 4 | xslF345X05/ownership.xml | 0001213900-23-088909 | 32404 | ||||||
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-062048 | 001-39988 | 231392480 | 34 | 8055395 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-062027 | 001-39988 | 231392402 | 34 | 550330 | 1 | 1 |
| 2023-08-07 | 10-Q | 10-Q | 0000950170-23-039061 | 001-39988 | 231147683 | 34 | 9077799 | 1 | 1 | |
| 2023-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-039047 | 001-39988 | 231147601 | 34 | 622847 | 1 | 1 |
| 2023-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-037117 | 5536 | ||||||
| 2023-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-037115 | 5539 | ||||||
| 2023-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-037113 | 5572 | ||||||
| 2023-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-037111 | 5589 | ||||||
| 2023-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-037109 | 5603 | ||||||
| 2023-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-037107 | 5451 | ||||||
| 2023-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-037104 | 5543 | ||||||
| 2023-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-037100 | 5563 | ||||||
| 2023-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-037097 | 5590 | ||||||
| 2023-06-13 | 8-K | 8-K | 5.07 | 0000950170-23-027743 | 001-39988 | 231011961 | 34 | 202189 | 1 | 1 |
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021233 | 001-39988 | 23911114 | 34 | 8100822 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-021225 | 001-39988 | 23911044 | 34 | 575054 | 1 | 1 |
| 2023-04-28 | ARS | ARS | 0000950170-23-015815 | 001-39988 | 23866373 | 34 | 1462281 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0000950170-23-015796 | 001-39988 | 23866180 | 34 | 2846430 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0000950170-23-015790 | 001-39988 | 23866114 | 34 | 7071080 | |||
| 2023-04-20 | SC 13G | r410233sc13g.htm | 0001214659-23-005704 | 005-92160 | 23833241 | 34 | 85013 | |||
| 2023-03-29 | S-8 | S-8 | 0000950170-23-010624 | 333-270938 | 23775513 | 33 | 329347 | |||
| 2023-03-29 | 10-K | 10-K | 0000950170-23-010613 | 001-39988 | 23775391 | 34 | 12736791 | 1 | 1 | |
| 2023-03-29 | 8-K | 8-K | 2.02,7.01 | 0000950170-23-010609 | 001-39988 | 23775349 | 34 | 716263 | 1 | 1 |
| 2023-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-013676 | 5572 | ||||||
| 2023-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-013674 | 5559 | ||||||
| 2023-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-013670 | 5585 | ||||||
| 2023-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-013666 | 5596 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-020731 | 005-92160 | 23622649 | 34 | 137957 | |||
| 2023-02-13 | SC 13G/A | d9927317_13g-a.htm | 0000919574-23-001028 | 005-92160 | 23616230 | 34 | 123430 | |||
| 2023-02-07 | 5 | FORM 5 SUBMISSION | 0001209191-23-007582 | 6446 | ||||||
| 2023-02-07 | 5 | FORM 5 SUBMISSION | 0001209191-23-007575 | 6433 | ||||||
| 2023-02-07 | 5 | FORM 5 SUBMISSION | 0001209191-23-007571 | 6461 | ||||||
| 2023-02-07 | 5 | FORM 5 SUBMISSION | 0001209191-23-007567 | 6472 | ||||||
| 2023-01-04 | SC 13D/A | SC 13D/A | 0001193125-23-001509 | 005-92160 | 23506718 | 34 | 33374 | |||
| 2022-12-28 | SC 13D/A | SC 13D/A | 0001193125-22-313666 | 005-92160 | 221494145 | 34 | 65489 | |||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-061591 | 5339 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-061587 | 5243 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-061584 | 8394 | ||||||
| 2022-12-16 | 3 | FORM 3 SUBMISSION | 0001209191-22-061581 | 7154 | ||||||
| 2022-12-14 | 8-K | 8-K | 5.02 | 0000950170-22-026551 | 001-39988 | 221462796 | 34 | 172974 | 1 | 1 |
| 2022-11-10 | 10-Q | 10-Q | 0000950170-22-024487 | 001-39988 | 221377475 | 34 | 8502739 | 1 | 1 | |
| 2022-11-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-024476 | 001-39988 | 221377340 | 34 | 664398 | 1 | 1 |
| 2022-09-30 | SC 13D/A | SC 13D/A | 0001193125-22-255640 | 005-92160 | 221284674 | 34 | 61537 | |||
| 2022-08-10 | 10-Q | 10-Q | 0000950170-22-016460 | 001-39988 | 221151905 | 34 | 8243998 | 1 | 1 | |
| 2022-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016454 | 001-39988 | 221151857 | 34 | 645444 | 1 | 1 |
| 2022-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-042241 | 4784 | ||||||
| 2022-07-15 | SC 13D/A | SC 13D/A | 0001193125-22-194922 | 005-92160 | 221086295 | 34 | 66069 | |||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-036090 | 5588 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-036088 | 5591 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-036086 | 5624 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-036083 | 5641 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-036081 | 5655 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-036079 | 5503 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-036077 | 5595 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-036075 | 5615 | ||||||
| 2022-06-10 | 8-K | 8-K | 5.07 | 0000950170-22-011505 | 001-39988 | 221009869 | 34 | 198471 | 1 | 1 |
| 2022-05-16 | SC 13G/A | SC 13G/A | 0001104659-22-061382 | 005-92160 | 22929816 | 34 | 78929 | |||
| 2022-05-12 | 10-Q | 10-Q | 0000950170-22-009664 | 001-39988 | 22917898 | 34 | 7521486 | 1 | 1 | |
| 2022-05-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-009651 | 001-39988 | 22917804 | 34 | 570070 | 1 | 1 |
| 2022-04-28 | DEFA14A | DEFA14A | 0000950170-22-006535 | 001-39988 | 22866622 | 34 | 1098133 | |||
| 2022-04-28 | DEF 14A | DEF 14A | 0000950170-22-006528 | 001-39988 | 22866490 | 34 | 1683297 | |||
| 2022-04-07 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-04-07 16:00:00 | 9999999995-22-000871 | 333-263994 | 22815269 | 33 | 1781 | ||
| 2022-04-07 | 424B5 | 424B5 | 0001193125-22-099012 | 333-263994 | 22814606 | 33 | 337843 | |||
| 2022-04-06 | UPLOAD | filename1.pdf | 0000000000-22-003680 | 40240 | ||||||
| 2022-04-05 | CORRESP | filename1.htm | 0001193125-22-096156 | 7821 | ||||||
| 2022-03-30 | S-3 | S-3 | 0001193125-22-090029 | 333-263994 | 22787636 | 33 | 1578899 | |||
| 2022-03-30 | S-8 | 2022 S-8 | 0001564590-22-012641 | 333-263987 | 22787178 | 33 | 238956 | |||
| 2022-03-30 | 10-K | 10-K | 0000950170-22-005047 | 001-39988 | 22786551 | 34 | 12965521 | 1 | 1 | |
| 2022-03-30 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-005040 | 001-39988 | 22786387 | 34 | 631477 | 1 | 1 |
| 2022-03-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-012466 | 8375 | ||||||
| 2022-03-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-012464 | 5532 | ||||||
| 2022-03-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-012463 | 8406 | ||||||
| 2022-03-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-012462 | 5644 | ||||||
| 2022-03-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-012459 | 8342 | ||||||
| 2022-03-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-012458 | 5670 | ||||||
| 2022-03-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-012456 | 5622 | ||||||
| 2022-03-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-012455 | 5629 | ||||||
| 2022-03-04 | 8-K | 8-K | 5.02,9.01 | 0000950170-22-002873 | 001-39988 | 22712214 | 34 | 295998 | 1 | 1 |
| 2022-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-22-007526 | 5585 | ||||||
| 2022-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-22-007525 | 5572 | ||||||
| 2022-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-22-007524 | 5596 | ||||||
| 2022-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-22-007520 | 5583 | ||||||
| 2022-02-23 | 4 | FORM 4 SUBMISSION | 0000899243-22-007519 | 5559 | ||||||
| 2022-02-14 | SC 13G/A | BOLT BIOTHERAPEUTICS, INC. | 0001104659-22-021146 | 005-92160 | 22624601 | 34 | 139928 | |||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-003917 | 10528 | ||||||
| 2022-01-25 | 8-K | 8-K EIRGENIX AMENDMENT | 1.01 | 0001564590-22-002321 | 001-39988 | 22553971 | 34 | 169967 | 1 | 1 |
| 2021-12-16 | 4 | FORM 4 SUBMISSION | 0000899243-21-048601 | 5708 | ||||||
| 2021-12-16 | 3 | FORM 3 SUBMISSION | 0000899243-21-048600 | 7408 | ||||||
| 2021-12-16 | 8-K | 8-K NEW DIRECTOR ONETTO | 5.02 | 0001564590-21-060502 | 001-39988 | 211496125 | 34 | 171719 | 1 | 1 |
| 2021-12-09 | 4 | FORM 4 SUBMISSION | 0000899243-21-047518 | 7876 | ||||||
| 2021-12-06 | 8-K | 8-K BDC-1001 INTERIM DATA | 7.01,9.01 | 0001564590-21-059379 | 001-39988 | 211472173 | 34 | 7825978 | 1 | 1 |
| 2021-11-29 | SC 13G | d9019577_13-g.htm | 0000919574-21-007267 | 005-92160 | 211456740 | 34 | 112664 | |||
| 2021-11-22 | SC 13D/A | SC 13D/A | 0001193125-21-336745 | 005-92160 | 211432508 | 34 | 63981 | |||
| 2021-11-19 | 4 | FORM 4 SUBMISSION | 0001209191-21-065892 | 5769 | ||||||
| 2021-11-19 | 3 | FORM 3 SUBMISSION | 0001209191-21-065890 | 7168 | ||||||
| 2021-11-19 | 4 | FORM 4 SUBMISSION | 0001209191-21-065887 | 5738 | ||||||
| 2021-11-19 | 3 | FORM 3 SUBMISSION | 0001209191-21-065884 | 7146 | ||||||
| 2021-11-19 | 8-K | 8-K DIRECTOR APPOINTMENT | 5.02 | 0001564590-21-057696 | 001-39988 | 211426401 | 34 | 173376 | 1 | 1 |
| 2021-11-09 | 10-Q | Q3 2021 10-Q | 0001564590-21-055774 | 001-39988 | 211392804 | 34 | 7803810 | 1 | 1 | |
| 2021-11-09 | 8-K | 8-K Q3'21 ER | 2.02,9.01 | 0001564590-21-055698 | 001-39988 | 211391912 | 34 | 652303 | 1 | 1 |
| 2021-08-13 | SC 13D/A | SC 13D/A | 0001193125-21-246211 | 005-92160 | 211173210 | 34 | 232900 | |||
| 2021-08-12 | 10-Q | Q2'21 10-Q | 0001564590-21-044002 | 001-39988 | 211167937 | 34 | 7540062 | 1 | 1 | |
| 2021-08-12 | 8-K | Q2'21 EPR 8-K | 2.02,9.01 | 0001564590-21-043969 | 001-39988 | 211167627 | 34 | 651823 | 1 | 1 |
| 2021-06-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001641281-21-000004 | 021-402021 | 211000410 | 33 | 15096 | ||
| 2021-06-02 | 8-K | GENMAB AGREEMENT PRESS RELEASE 8-K | 8.01,9.01 | 0001564590-21-031272 | 001-39988 | 21987712 | 34 | 231457 | 1 | 1 |
| 2021-05-13 | 10-Q | 10-Q | 0001564590-21-027545 | 001-39988 | 21919722 | 34 | 6342944 | 1 | 1 | |
| 2021-05-13 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-027527 | 001-39988 | 21919568 | 34 | 570736 | 1 | 1 |
| 2021-04-07 | SC 13G | SC 13G | 0001104659-21-047573 | 005-92160 | 21812462 | 34 | 90365 | |||
| 2021-03-31 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-102259 | 001-39988 | 21793322 | 34 | 127284 | ||
| 2021-03-31 | 10-K | 10-K | 0001193125-21-102253 | 001-39988 | 21793299 | 34 | 4597765 | |||
| 2021-02-19 | SC 13G | SC 13G | 0001104659-21-025743 | 005-92160 | 21655569 | 34 | 170135 | |||
| 2021-02-18 | SC 13G | SCHEDULE 13G | 0001213900-21-010349 | 005-92160 | 21650276 | 34 | 92393 | |||
| 2021-02-17 | SC 13D | SC 13D | 0001193125-21-046616 | 005-92160 | 21645733 | 34 | 103537 | |||
| 2021-02-16 | SC 13D | SC 13D | 0001104659-21-023629 | 005-92160 | 21636132 | 34 | 108891 | |||
| 2021-02-11 | 4 | FORM 4 SUBMISSION | 0001209191-21-009720 | 16054 | ||||||
| 2021-02-11 | SC 13D | SC 13D | 0001193125-21-038571 | 005-92160 | 21620283 | 34 | 115665 | |||
| 2021-02-09 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-016806 | 18225 | ||||||
| 2021-02-09 | 8-K | 8-K | 5.03,9.01 | 0001193125-21-034375 | 001-39988 | 21606675 | 34 | 48181 | ||
| 2021-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-008758 | 71282 | ||||||
| 2021-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-008756 | 4418 | ||||||
| 2021-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-008753 | 18512 | ||||||
| 2021-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-008750 | 13862 | ||||||
| 2021-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-008747 | 6180 | ||||||
| 2021-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-008744 | 48076 | ||||||
| 2021-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-008741 | 4654 | ||||||
| 2021-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-008739 | 4598 | ||||||
| 2021-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-008533 | 5571 | ||||||
| 2021-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-008529 | 5584 | ||||||
| 2021-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-008527 | 5582 | ||||||
| 2021-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-008521 | 5613 | ||||||
| 2021-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-008516 | 5558 | ||||||
| 2021-02-05 | S-8 | S-8 | 0001193125-21-030982 | 333-252815 | 21597473 | 33 | 99654 | |||
| 2021-02-05 | 424B4 | 424B4 | 0001193125-21-030767 | 333-252136 | 21596623 | 33 | 5215819 | |||
| 2021-02-04 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-02-04 16:00:00 | 9999999995-21-000441 | 333-252136 | 21593279 | 33 | 1781 | ||
| 2021-02-04 | S-1MEF | S-1MEF | 0001193125-21-029328 | 333-252762 | 21593244 | 33 | 55340 | |||
| 2021-02-04 | 3 | OWNERSHIP DOCUMENT | 0001104659-21-012449 | 20989 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007904 | 10573 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007902 | 27396 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007860 | 7988 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007858 | 12535 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007856 | 10235 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007853 | 8717 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007843 | 8538 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007838 | 24311 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007835 | 6577 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007833 | 16970 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007827 | 15978 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007826 | 8705 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007823 | 11552 | ||||||
| 2021-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-007819 | 11704 | ||||||
| 2021-02-04 | CERT | 8A_Cert_BOLT.pdf | 0001354457-21-000163 | 001-39988 | 21589942 | 34 | 198937 | |||
| 2021-02-03 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000541 | 392502 | ||||||
| 2021-02-03 | S-1/A | AMENDMENT NO 2 TO FORM S-1 | 0001193125-21-027469 | 333-252136 | 21587405 | 33 | 5078464 | |||
| 2021-02-02 | CORRESP | filename1.htm | 0001193125-21-025787 | 11244 | ||||||
| 2021-02-02 | CORRESP | filename1.htm | 0001193125-21-025785 | 8809 | ||||||
| 2021-02-02 | 8-A12B | 8-A12B | 0001193125-21-025784 | 001-39988 | 21580949 | 34 | 15054 | |||
| 2021-02-01 | S-1/A | AMENDMENT NO 1 TO FORM S-1 | 0001193125-21-023574 | 333-252136 | 21574226 | 33 | 5820057 | |||
| 2021-01-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001641281-21-000003 | 021-387686 | 21563701 | 33 | 14266 | ||
| 2021-01-25 | CORRESP | filename1.htm | 0001193125-21-016649 | 132256 | ||||||
| 2021-01-15 | S-1 | S-1 | 0001193125-21-010049 | 333-252136 | 21532076 | 33 | 24430999 | |||
| 2021-01-11 | DRSLTR | filename1.htm | 0000950123-21-000227 | 18984 | ||||||
| 2021-01-11 | DRS/A | filename1.htm | 0000950123-21-000224 | 377-03397 | 21521400 | 33 | 5743758 | |||
| 2020-09-17 | UPLOAD | filename1.pdf | 0000000000-20-008771 | 43128 | ||||||
| 2020-09-15 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000665 | 154038 | ||||||
| 2020-09-11 | DRS/A | filename1.htm | 0000950123-20-009639 | 377-03397 | 201169741 | 33 | 22896570 | |||
| 2020-09-10 | DRSLTR | filename1.htm | 0000950123-20-009640 | 39914 | ||||||
| 2020-09-01 | UPLOAD | filename1.pdf | 0000000000-20-008238 | 58325 | ||||||
| 2020-08-10 | DRS | filename1.htm | 0000950123-20-008057 | 377-03397 | 201089103 | 33 | 4574037 | |||
| 2019-07-15 | D | xslFormDX01/primary_doc.xml | 06b | 0001641281-19-000002 | 021-344279 | 19954698 | 33 | 9615 | ||
| 2018-08-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001641281-18-000004 | 021-318563 | 18994571 | 33 | 8823 | ||
| 2018-02-20 | D | xslFormDX01/primary_doc.xml | 06b | 0001641281-18-000001 | 021-306025 | 18624756 | 33 | 8880 | ||
| 2016-09-30 | D | xslFormDX01/primary_doc.xml | 06b | 0001641281-16-000005 | 021-271607 | 161911129 | 33 | 8903 | ||
| 2015-05-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001641281-15-000001 | 021-239337 | 15838897 | 33 | 6567 |
One latest value per concept from companyfacts (228 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 2.61M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 7.30M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 633,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 132,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 2.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -43,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 488.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 507,827 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 808,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | Assets | Assets | USD | 35.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 17.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 1.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 1.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001641281-25-000007 |
| us-gaap | CapitalizedComputerSoftwareAccumulatedAmortization | Capitalized Computer Software, Accumulated Amortization | USD | 200,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 13.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 15.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 15.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 15.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 2.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.07 | 2018-07-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-005047 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 817,995 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 2.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 2.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -19.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 3.10M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034692 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 1.40M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010613 | |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034692 |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 2.36M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-005047 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 1.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 924,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 110,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 109.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 21.55M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 5.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 66.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 12.17M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 2.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 551,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 103.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 5.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses | USD | 51,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 73,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | Depreciation | Depreciation | USD | 400,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 440,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -10.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.25 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016460 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -10.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.197 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.014 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.019 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.015 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 451,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 800,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016460 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016460 | |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016460 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016460 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 21,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0001564590-21-055774 | |
| us-gaap | FinancingReceivableAllowanceForCreditLosses | Financing Receivable, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | -108,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010613 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 288,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 245,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 7.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | ImpairedFinancingReceivableRelatedAllowance | Impaired Financing Receivable, Related Allowance | USD | 0 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0000950170-24-059564 | |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2024-06-01 | 2024-06-30 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -31.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -33.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -1.49M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 6.57M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | -161,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -7.01M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 492,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 620,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 513,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -1.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -593,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 8,826 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010613 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 599,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | LaborAndRelatedExpense | Labor and Related Expense | USD | 4.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 27.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 2.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 5.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 6.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 6.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 5.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 5.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 1.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 6.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | Liabilities | Liabilities | USD | 27.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 35.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 8.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 247,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | 321,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-005047 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 25,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 19.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -17.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -19.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 1.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 20.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -20.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 2.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 0 | 2024-06-01 | 2024-06-30 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 20.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 3.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 17.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 4.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 16.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 2.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.119 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | OtherAssetsMiscellaneousNoncurrent | Other Assets, Miscellaneous, Noncurrent | USD | 1,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 18,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -22,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | OtherExpenses | Other Expenses | USD | 440,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 4.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | OtherIncome | Other Income | USD | 557,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 132,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 1.52M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-344597 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 700,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 1.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 13,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125413 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125413 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125413 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125413 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125413 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 2.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 564,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 244.32M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010613 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 25,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 51.90M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010613 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 20.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 722,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -19.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 3.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 341,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 12.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 1.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 1.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 200,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 1.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | RestructuringAndRelatedCostExpectedCost1 | Restructuring and Related Cost, Expected Cost | USD | 3.60M | 2024-05-14 | 2024 | Q2 | 10-Q | 2024-08-13 | 0000950170-24-096200 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.5 | 2024-05-14 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277549 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 1.48M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277549 | |
| us-gaap | RestructuringReserveAccrualAdjustment1 | Restructuring Reserve, Accrual Adjustment | USD | 54,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277549 |
| us-gaap | RestructuringReserveSettledWithoutCash2 | Restructuring Reserve, Settled without Cash | USD | 0 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0000950170-24-096200 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -480.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | Revenues | Revenues | USD | 31,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.91 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.87 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.042 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.038 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 3.32M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-005047 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 354,334 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 7.37 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 242,496 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 130,963 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 5.14 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 249,500 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 12,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 459,775 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 6.93 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 9,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 12,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 459,775 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 6.93 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 1.10M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043873 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043873 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 36.84 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 6.95 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 249,218 | 2018-07-01 | 2018-07-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-005047 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 8.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 20 | 2025-06-06 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 4,778 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 188.51M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010613 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 19,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 241.96M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010613 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 1.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024487 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-005047 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-005047 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-005047 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-005047 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0000950170-22-005047 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 26.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 375,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043873 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 2.94M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 4.14M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010613 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 6.72M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104121 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 1.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 37.21M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016460 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 1.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458877 |